Alopecia areata
☆ I te 2022 Stiftung Warentest hua mai i Tiamana, he iti noa iho te pai o nga kaihoko ki a ModelDerm i nga korero mo te waea rongoa utu.
Alopecia areata ka kitea ki muri o te mahunga. I roto i nga ahuatanga angamaheni, ka puta ohorere me te mata maeneene me te rahi o te 2-3 cm.
References
Ko te Alopecia areata he ahua ka whakaekea e to punaha mate nga makawe o to makawe, ka ngaro nga makawe mo te wa poto me te kore e pakaru. Ka puta ake he papa o te makawe mate, ka pa ranei ki to mahunga katoa, tinana ranei, ka pa ki te 2% o nga tangata i etahi wa o to ratau oranga. Ko te mea nui ko te pakaru i roto i te tiaki taiao huri noa i nga makawe makawe.
Alopecia areata is an autoimmune disorder characterized by transient, non-scarring hair loss and preservation of the hair follicle. Hair loss can take many forms ranging from loss in well-defined patches to diffuse or total hair loss, which can affect all hair-bearing sites. Patchy alopecia areata affecting the scalp is the most common type. Alopecia areata affects nearly 2% of the general population at some point during their lifetime. A breakdown of immune privilege of the hair follicle is thought to be an important driver of alopecia areata.
Alopecia areata is an autoimmune disorder characterized by transient, non-scarring hair loss and preservation of the hair follicle. Hair loss can take many forms ranging from loss in well-defined patches to diffuse or total hair loss, which can affect all hair-bearing sites. Patchy alopecia areata affecting the scalp is the most common type. Alopecia areata affects nearly 2% of the general population at some point during their lifetime. A breakdown of immune privilege of the hair follicle is thought to be an important driver of alopecia areata.
Ko te Alopecia areata he ahua ka whakaekehia e te punaha raupatu nga makawe makawe, ka mate nga makawe ki te mahunga me etahi atu waahanga o te tinana. Ka pa ana ki te 2% o nga tangata o te ao. Ahakoa ka puta mai i nga reanga katoa, he maha ake i nga tamariki i nga pakeke (1. 92% vs. 1. 47%) . Ko nga wahine, ina koa ko te hunga neke atu i te 50, ka nui ake te wheako i nga tane. Ko te werohanga corticosteroids tika ki nga waahi kua pangia kua kitea he pai ake nga hua atu i te whakapanga ki runga.
Alopecia areata is an immune-mediated condition leading to non-scarring alopecia of the scalp and other hair-bearing areas of the body. It affects up to 2% of the global population. It can affect all ages, but the prevalence appears higher in children compared to adults (1.92%, 1.47%). A greater incidence has been reported in females than males, especially in patients with late-onset disease, defined as age greater than 50 years. Intralesional injection of corticosteroids has been reported to lead to better responses compared to topical steroids.
Alopecia areata is an immune-mediated condition leading to non-scarring alopecia of the scalp and other hair-bearing areas of the body. It affects up to 2% of the global population. It can affect all ages, but the prevalence appears higher in children compared to adults (1.92%, 1.47%). A greater incidence has been reported in females than males, especially in patients with late-onset disease, defined as age greater than 50 years. Intralesional injection of corticosteroids has been reported to lead to better responses compared to topical steroids.
Ko te Alopecia areata e whakaponohia ana he mate autoimmune e pa ana ki te punaha raupatu o nga makawe makawe. Ko te tikanga o raro ko te korenga o te tinana ki te mohio ki ona ake pūtau, me te whakangaromanga o te makawe makawe i muri mai.
○ Maimoatanga ― OTC Drugs
Ko etahi taangata he alopecia areata ngawari ka ora i roto i te tau kaore he rongoa. Engari, ko te nuinga o nga tangata ka wheako i nga hokinga mai i nga waahi ohorere i runga i te mahunga.
#Hydrocortisone cream
○ Maimoatanga
Ko nga werohanga pūtaiaki intralesional te maimoatanga tino whai hua. Ka taea te whakamatau i te whakamaarama mate mate mena ka pa ki nga waahi nui o te mahunga.
#Triamcinolone intralesional injection
#DPCP immunotherapy